Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Pearson

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Vaccine|April 16, 2010
Vaccination of commercial broiler chicks against avian metapneumovirus infection: a comparison of drinking-water, spray and oculo-oral delivery methodsKannan Ganapathy, Andrew Bufton, Andrew Pearson, et al.
Retinal Cases & Brief Reports|November 13, 2014
Bilateral central retinal artery occlusion in a patient with acute pancreatitisPeter J Timoney, James C Pate, P Andrew Pearson, et al.
Ophthalmology and Therapy|December 16, 2014
Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian PopulationVirender S Sangwan, P Andrew Pearson, Hemanth Paul, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 4, 2011
Gold nanoparticle-decorated keggin ions/TiO2 photococatalyst for improved solar light photocatalysisAndrew Pearson, Harit Jani, Kourosh Kalantar-zadeh, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|September 20, 2012
Decoration of TiO2 nanotubes with metal nanoparticles using polyoxometalate as a UV-switchable reducing agent for enhanced visible and solar light photocatalysisAndrew Pearson, Haidong Zheng, Kourosh Kalantar-Zadeh, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 29, 2004
Ocular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year periodJean-Yves Driot, Gary D Novack, Kay D Rittenhouse, et al.
Scientific Reports|February 14, 2020
Speleothem growth intervals reflect New Zealand montane vegetation response to temperature change over the last glacial cycleJohn Hellstrom, Kale Sniderman, Russell Drysdale, et al.
BMC Medical Education|November 9, 2018
Analysis of MCQ and distractor use in a large first year Health Faculty Foundation Program: assessing the effects of changing from five to four optionsNicolette Fozzard, Andrew Pearson, Eugene du Toit, et al.
Ophthalmology|May 13, 2006
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical studyGlenn J Jaffe, Daniel Martin, David Callanan, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 17, 2016
Characterization of Intraocular Pressure Increases and Management Strategies Following Treatment With Fluocinolone Acetonide Intravitreal Implants in the FAME TrialsRichard K Parrish, Peter A Campochiaro, P Andrew Pearson, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Vaccine|April 16, 2010
Vaccination of commercial broiler chicks against avian metapneumovirus infection: a comparison of drinking-water, spray and oculo-oral delivery methodsKannan Ganapathy, Andrew Bufton, Andrew Pearson, et al.
Retinal Cases & Brief Reports|November 13, 2014
Bilateral central retinal artery occlusion in a patient with acute pancreatitisPeter J Timoney, James C Pate, P Andrew Pearson, et al.
Ophthalmology and Therapy|December 16, 2014
Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian PopulationVirender S Sangwan, P Andrew Pearson, Hemanth Paul, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 4, 2011
Gold nanoparticle-decorated keggin ions/TiO2 photococatalyst for improved solar light photocatalysisAndrew Pearson, Harit Jani, Kourosh Kalantar-zadeh, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|September 20, 2012
Decoration of TiO2 nanotubes with metal nanoparticles using polyoxometalate as a UV-switchable reducing agent for enhanced visible and solar light photocatalysisAndrew Pearson, Haidong Zheng, Kourosh Kalantar-Zadeh, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 29, 2004
Ocular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year periodJean-Yves Driot, Gary D Novack, Kay D Rittenhouse, et al.
Scientific Reports|February 14, 2020
Speleothem growth intervals reflect New Zealand montane vegetation response to temperature change over the last glacial cycleJohn Hellstrom, Kale Sniderman, Russell Drysdale, et al.
BMC Medical Education|November 9, 2018
Analysis of MCQ and distractor use in a large first year Health Faculty Foundation Program: assessing the effects of changing from five to four optionsNicolette Fozzard, Andrew Pearson, Eugene du Toit, et al.
Ophthalmology|May 13, 2006
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical studyGlenn J Jaffe, Daniel Martin, David Callanan, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 17, 2016
Characterization of Intraocular Pressure Increases and Management Strategies Following Treatment With Fluocinolone Acetonide Intravitreal Implants in the FAME TrialsRichard K Parrish, Peter A Campochiaro, P Andrew Pearson, et al.
Pageof 9